YU41692B - Process for obtaining spiroquidyl hydantion - Google Patents

Process for obtaining spiroquidyl hydantion

Info

Publication number
YU41692B
YU41692B YU131/80A YU13180A YU41692B YU 41692 B YU41692 B YU 41692B YU 131/80 A YU131/80 A YU 131/80A YU 13180 A YU13180 A YU 13180A YU 41692 B YU41692 B YU 41692B
Authority
YU
Yugoslavia
Prior art keywords
spiroquidyl
hydantion
obtaining
spiroquidyl hydantion
obtaining spiroquidyl
Prior art date
Application number
YU131/80A
Other languages
English (en)
Other versions
YU13180A (en
Inventor
R C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU13180A publication Critical patent/YU13180A/xx
Publication of YU41692B publication Critical patent/YU41692B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
YU131/80A 1979-01-22 1980-01-18 Process for obtaining spiroquidyl hydantion YU41692B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,278 US4176185A (en) 1979-01-22 1979-01-22 Spiro-quinolylhydantoins

Publications (2)

Publication Number Publication Date
YU13180A YU13180A (en) 1983-01-21
YU41692B true YU41692B (en) 1987-12-31

Family

ID=21715098

Family Applications (1)

Application Number Title Priority Date Filing Date
YU131/80A YU41692B (en) 1979-01-22 1980-01-18 Process for obtaining spiroquidyl hydantion

Country Status (22)

Country Link
US (1) US4176185A (de)
EP (1) EP0014079B1 (de)
JP (1) JPS5840959B2 (de)
KR (1) KR830001940A (de)
AR (1) AR222685A1 (de)
AT (1) AT365588B (de)
AU (1) AU514271B2 (de)
CA (1) CA1140928A (de)
DE (1) DE3060079D1 (de)
DK (1) DK156399C (de)
EG (1) EG15085A (de)
ES (1) ES8103090A1 (de)
FI (1) FI69308C (de)
GR (1) GR72408B (de)
IE (1) IE49365B1 (de)
IL (1) IL59177A (de)
NO (1) NO152172C (de)
NZ (1) NZ192650A (de)
PH (1) PH15472A (de)
PT (1) PT70716A (de)
YU (1) YU41692B (de)
ZA (1) ZA80344B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065393B1 (de) * 1981-05-12 1984-12-27 Imperial Chemical Industries Plc Pyrrolderivate
FI901087A0 (fi) * 1987-09-04 1990-03-02 Pfizer Azolidindionderivat.
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3876659A (en) * 1970-09-18 1975-04-08 Sandoz Ag Spiro tricyclic isoindolines
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins

Also Published As

Publication number Publication date
JPS55108873A (en) 1980-08-21
EP0014079B1 (de) 1981-11-18
GR72408B (de) 1983-11-02
NZ192650A (en) 1984-04-27
EG15085A (en) 1986-12-30
FI69308C (fi) 1986-01-10
IL59177A0 (en) 1980-05-30
DK156399C (da) 1990-01-08
IL59177A (en) 1982-11-30
FI800163A7 (fi) 1980-07-23
CA1140928A (en) 1983-02-08
IE49365B1 (en) 1985-09-18
NO152172B (no) 1985-05-06
AU514271B2 (en) 1981-01-29
ES487923A0 (es) 1981-02-16
YU13180A (en) 1983-01-21
DE3060079D1 (en) 1982-01-21
AU5476680A (en) 1980-07-31
IE800109L (en) 1980-07-22
NO794318L (no) 1980-07-23
DK24280A (da) 1980-07-23
KR830001940A (ko) 1983-05-19
AT365588B (de) 1982-01-25
DK156399B (da) 1989-08-14
US4176185A (en) 1979-11-27
ATA26780A (de) 1981-06-15
FI69308B (fi) 1985-09-30
ZA80344B (en) 1981-02-25
JPS5840959B2 (ja) 1983-09-08
ES8103090A1 (es) 1981-02-16
PT70716A (en) 1980-02-01
AR222685A1 (es) 1981-06-15
NO152172C (no) 1985-08-14
PH15472A (en) 1983-01-24
EP0014079A1 (de) 1980-08-06

Similar Documents

Publication Publication Date Title
YU11380A (en) Process for obtaining n-benzyl-imidazole
YU65680A (en) Process for obtaining 9-amino-alkylfluorene
YU123880A (en) Process for preparing pyrazinobenzoidiazepines
YU177880A (en) Process for obtaining acyl-carbamides
DE3061037D1 (en) Process for preparing dimethylaminosilanes
YU41208B (en) Process for obtaining thiazolylidene - oxo -propionitrile
YU43306B (en) Process for obtaining 2-amino-3-benzoyl-phenylacetamides
DE3060089D1 (en) Process for preparing 1-amino-2-phenoxy-4-hydroxy-anthraquinone
YU13180A (en) Process for obtaining spiro-quinolyl-hydantoin
YU41738B (en) Process for obtaining 1,2,4-oxadiazoline-5-one derivatives
YU43534B (en) Process for obtaining pure chlorocyan
GB2052495B (en) Process for making hexafluorotriallylisocyanurate
YU108580A (en) Process for obtaining alkoxyalkylidene hydrazinopyridazine
YU44734B (en) Process for obtaining 3-halogen-cephalosporin iminohalogenids
YU259680A (en) Process for obtaining acylcarbamides
YU63980A (en) Process for obtaining n-sulfinyl-carbamates
DE3060850D1 (en) Process for preparing naphthalenesulphochloride
YU41415B (en) Process for obtaining omega-lactams
YU310680A (en) Process for obtaining vanadyl-hydrate
YU43221B (en) Process for obtaining imidazobenzodiazepine
YU90680A (en) Process for obtaining hydroxyimino-substituted aminoacetonitriles
YU114983A (en) Process for making hydrocyanide
EG14822A (en) Process for preparing 5-halopyrimides
DE3063194D1 (en) Process for preparing cyclopentenolones
YU297780A (en) Process for obtaining glucoso-isomerase